Robert Leo Murphy

  • 12565 Citations
1975 …2024
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1975 2019

Filter
Review article
2019
Smoking Cessation
Nicotine
Meta-Analysis
Odds Ratio
Confidence Intervals
2018

Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature

Silas, O. A., Achenbach, C. J., Murphy, R. L., Hou, L., Sagay, S. A., Banwat, E., Adoga, A. A., Musa, J. & French, D. D., Jan 2 2018, In : Expert Review of Vaccines. 17, 1, p. 91-98 8 p.

Research output: Contribution to journalReview article

Papillomaviridae
Cost-Benefit Analysis
Vaccination
Uterine Cervical Neoplasms
Costs and Cost Analysis
2017
6 Citations (Scopus)
uterine cervical neoplasms
systematic review
meta-analysis
Uterine Cervical Neoplasms
Meta-Analysis
3 Citations (Scopus)

The most frequent Mycobacterium tuberculosis complex families in Mali (2006-2016) based on spoligotyping

Togo, A. C. G., Kodio, O., Diarra, B., Sanogo, M., Coulibaly, G., Bane, S., Diallo, F., Somboro, A. M., Cisse, A. B., Baya, B., Goita, D., Diabate, S., Kone, B., Sarro, Y. D. S., Maiga, M., Toloba, Y., Belson, M., Orsega, S., Dao, S., Murphy, R. L. & 3 others, Siddiqui, S., Doumbia, S. & Diallo, S., Oct 1 2017, In : International Journal of Mycobacteriology. 6, 4, p. 379-386 8 p.

Research output: Contribution to journalReview article

Mali
Mycobacterium tuberculosis
Tuberculosis
Drug Resistance
Cross-Sectional Studies
2016
4 Citations (Scopus)

Perspective piece clinical research and the training of host country investigators: Essential health priorities for disease-endemic regions

Koita, O. A., Murphy, R. L., Fongoro, S., Diallo, B., Doumbia, S. O., Traoré, M. & Krogstad, D. J., Feb 1 2016, In : American Journal of Tropical Medicine and Hygiene. 94, 2, p. 253-257 5 p.

Research output: Contribution to journalReview article

Health Priorities
Endemic Diseases
Western Africa
Ebola Hemorrhagic Fever
Research Personnel
7 Citations (Scopus)

Perspectives for immunotherapy: Which applications might achieve an HIV functional cure?

Vieillard, V., Gharakhanian, S., Lucar, O., Katlama, C., Launay, O., Autran, B., Tsong Fang, R. H., Crouzet, J., Murphy, R. L. & Debré, P., Jan 1 2016, In : Oncotarget. 7, 25, p. 38946-38958 13 p.

Research output: Contribution to journalReview article

Immunotherapy
HIV
Therapeutics
Neutralizing Antibodies
Virulence
2012
5 Citations (Scopus)

Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection

Akanbi, M. O., Scarci, K., Taiwo, B. O. & Murphy, R. L., Jan 1 2012, In : Expert Opinion on Pharmacotherapy. 13, 1, p. 65-79 15 p.

Research output: Contribution to journalReview article

Reverse Transcriptase Inhibitors
Nucleosides
HIV Infections
Nucleotides
HIV
64 Citations (Scopus)

The history of antiretroviral therapy and of its implementation in resource-limited areas of the world

Vella, S., Schwartländer, B., Sow, S. P., Eholie, S. P. & Murphy, R. L., Jun 19 2012, In : AIDS. 26, 10, p. 1231-1241 11 p.

Research output: Contribution to journalReview article

History
HIV
Public Health
History of Medicine
Drug Industry
2010
10 Citations (Scopus)

Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV

Achenbach, C. J., Scarsi, K. K. & Murphy, R. L., Jan 1 2010, In : Advances in Therapy. 27, 1, p. 1-16 16 p.

Research output: Contribution to journalReview article

HIV
Therapeutics
Reverse Transcriptase Inhibitors
Viral Load
Nucleosides
10 Citations (Scopus)

Chicago medical response to the 2010 earthquake in Haiti: Translating academic collaboration into direct humanitarian response

Babcock, C., Baer, C., Bayram, J. D., Chamberlain, S., Chan, J. L., Galvin, S. R., Kim, J., Kinet, M., Kysia, R. F., Lin, J., Malik, M., Murphy, R. L., Olopade, C. S. & Theodosis, C., Jun 1 2010, In : Disaster Medicine and Public Health Preparedness. 4, 2, p. 169-173 5 p.

Research output: Contribution to journalReview article

Haiti
Earthquakes
Organizations
Disasters
Volunteers
23 Citations (Scopus)

Novel antiretroviral combinations in treatment-experienced patients with HIV infection: Rationale and results

Taiwo, B. O., Murphy, R. L. & Katlama, C., Sep 2 2010, In : Drugs. 70, 13, p. 1629-1642 14 p.

Research output: Contribution to journalReview article

HIV Infections
Ritonavir
HIV
etravirine
Protease Inhibitors
2009
11 Citations (Scopus)

Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection

Katlama, C. & Murphy, R., Dec 1 2009, In : Therapeutics and Clinical Risk Management. 5, 1, p. 331-340 10 p.

Research output: Contribution to journalReview article

Integrase Inhibitors
Patient treatment
HIV Infections
DNA
Enzymes
11 Citations (Scopus)

Management of antiretroviral failure and resistance in developing countries

Hawkins, C. A. & Murphy, R. L., Nov 1 2009, In : Current Opinion in HIV and AIDS. 4, 6, p. 538-544 7 p.

Research output: Contribution to journalReview article

Developing Countries
HIV
Therapeutics
Salvage Therapy
Drug Resistance
2008
10 Citations (Scopus)
Africa South of the Sahara
CD4 Lymphocyte Count
T-Lymphocytes
HIV
Opportunistic Infections
2007
1 Citation (Scopus)
Developed Countries
Epidemiologic Studies
HIV
Pharmaceutical Preparations
Therapeutics
2005
33 Citations (Scopus)

Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection

Wainberg, M. A., Sawyer, J. P. C., Montaner, J. S. G., Murphy, R. L., Kuritzkes, D. R. & Raffi, F., Jun 15 2005, In : Antiviral Therapy. 10, 1, p. 13-28 16 p.

Research output: Contribution to journalReview article

Reverse Transcriptase Inhibitors
Nucleosides
HIV Infections
Population
Therapeutics
2004
15 Citations (Scopus)

Evaluating therapeutic vaccines in patients infected with HIV

Autran, B., Costagliola, D., Murphy, R. & Katlama, C., Aug 1 2004, In : Expert Review of Vaccines. 3, 4 SUPPL.

Research output: Contribution to journalReview article

Vaccines
HIV
Therapeutics
AIDS Vaccines
Virus Diseases
2003
44 Citations (Scopus)

European guidelines for the clinical management and treatment of HIV-infected adults in Europe

Murphy, R. L., Gazzard, B. & Clumeck, N., Jun 1 2003, In : AIDS. 17, SUPPL. 2

Research output: Contribution to journalReview article

HIV
Guidelines
47 Citations (Scopus)

The Pavia consensus statement

Volberding, P. A., Murphy, R. L., Barbaro, G., Barbarini, G., Bruno, R., Cirelli, A., Currie, P. F., Di Lorenzo, G., Fantoni, M., Filice, G., Galli, M., Grisorio, B., Moroni, M., Recusani, F., Sacchi, P., Scevola, D., Stein, J. H., Torre, D. & Vittecoq, D., Jan 1 2003, In : AIDS. 17, SUPPL. 1

Research output: Contribution to journalReview article

Highly Active Antiretroviral Therapy
Drug Interactions
HIV Infections
Cardiovascular Diseases
2002
42 Citations (Scopus)

Switch studies: A review

Murphy, R. L. & Smith, W. J., Jun 8 2002, In : HIV Medicine. 3, 2, p. 146-155 10 p.

Research output: Contribution to journalReview article

Reverse Transcriptase Inhibitors
Protease Inhibitors
Nucleosides
Lipodystrophy
Lipids
2000
71 Citations (Scopus)

Lopinavir

Hurst, M., Faulds, D., Markowitz, M. & Murphy, R. L., Dec 1 2000, In : Drugs. 60, 6, p. 1371-1381 11 p.

Research output: Contribution to journalReview article

Lopinavir
Ritonavir
Protease Inhibitors
Nevirapine
Reverse Transcriptase Inhibitors
178 Citations (Scopus)

Practice guidelines for the management of patients with sporotrichosis

Kauffman, C. A., Hajjeh, R., Chapman, S. W., Brasington, L., Greisberger, C., Hewitt, R., Reichman, R., Stiffler, T., Conklin, M., Klebert, M., Fass, R. J., Para, M. F., Neidig, J. L., Kessler, H., Murphy, R., Pulvirenti, J., Skahan, K., Kralovic, S., Daria, D., Daniel, P. & 31 others, Baker, D., Higgins, M., Apuzzo, L., Akavia, E., Vidic, M., Rosenwald, V., Dowling, J., Hooton, T., Collier, A., Royer, B., Novak, K., Johnson, S. C., Madinger, N., Fiorillo, S., Magee, C., Merrill, K. W., Squires, K. E., Davis, D., Hill, R. H., Black, J., Goldman, M., Todd, K., Nixon, H., Gripshover, B., Krzemien, H., Sprosty, R., Johnson, R., Millard, M., Oshita, L., Ogata-Arakaki, D. & Mycoses Study Group, Jan 1 2000, In : Clinical Infectious Diseases. 30, 4, p. 684-687 4 p.

Research output: Contribution to journalReview article

Sporotrichosis
Practice Management
Practice Guidelines
Itraconazole
Therapeutics
1997

Activity and safety of stavudine

Murphy, R. L., Dec 1 1997, In : Antiviral Therapy. 2, SUPPL.3, p. 75-79 5 p.

Research output: Contribution to journalReview article

Stavudine
Zidovudine
Safety
HIV-1
Nucleosides
1996
120 Citations (Scopus)

Nevirapine: A review of its development, pharmacological profile and potential for clinical use

Murphy, R. L. & Montaner, J., Jan 1 1996, In : Expert Opinion on Investigational Drugs. 5, 9, p. 1183-1199 17 p.

Research output: Contribution to journalReview article

Nevirapine
Pharmacology
Reverse Transcriptase Inhibitors
Zidovudine
Nucleosides
1994
1 Citation (Scopus)

Clinical aspects of HIV infection and AIDS: Prevention and treatment of opportunistic infections

Murphy, R. L., Feb 23 1994, In : Current Opinion in Infectious Diseases. 7, 1, p. 108-113 6 p.

Research output: Contribution to journalReview article

Opportunistic Infections
HIV Infections
Acquired Immunodeficiency Syndrome
Therapeutics
Poisons
1988

AIDS.

Murphy, R. L. & Phair, J. P., Jan 1 1988, In : Comprehensive Therapy. 14, 1, p. 3-12 10 p.

Research output: Contribution to journalReview article

Acquired Immunodeficiency Syndrome
Retroviridae Infections
HIV
Opportunistic Infections
Hepatitis B